Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia

US Patent 8158583 · Granted Apr 17, 2012

Estimated economic value: $14,829,000

Assignee

Inventors

View full patent text on Google Patents →